13
Methods of analysing healthcare costs in lung cancer CT-screening Jakob Fraes Rasmussen, [email protected]

Methods of analysing healthcare costs in l ung c ancer CT-screening

  • Upload
    noma

  • View
    31

  • Download
    0

Embed Size (px)

DESCRIPTION

Methods of analysing healthcare costs in l ung c ancer CT-screening. Does lung cancer CT screening lead to more healthcare use ?. Healthcare costs in 12 months. Healthcare costs in 12 months. Healthcare costs in 12 months. Groups analysed:. - PowerPoint PPT Presentation

Citation preview

Page 1: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Methods of analysing healthcare costs in lung cancer CT-screening

Jakob Fraes Rasmussen, [email protected]

Page 2: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Jakob Fraes Rasmussen, [email protected]

Does lung cancer CT screening lead to more healthcare use?

Page 3: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Jakob Fraes Rasmussen, [email protected]

Page 4: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Jakob Fraes Rasmussen, [email protected]

Healthcare costs in 12 months

Healthcare costs in 12 months

Healthcare costs in 12 months

Page 5: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Groups analysed:

Jakob Fraes Rasmussen, [email protected]

Page 6: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Jakob Fraes Rasmussen, [email protected]

Page 7: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Jakob Fraes Rasmussen, [email protected]

0 1 2 3 4 5 6 7 8 9 10 11

Distribution of Healthcare utilisation in the hospital sector is right skewed

No. of events

Page 8: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Prevalence of healthcare use in the diagnostic groups compared with the control group

Jakob Fraes Rasmussen, [email protected]

GP = General Practitioner

Page 9: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

The quantity of healthcare use in the diagnostic groups compared with the control group

Jakob Fraes Rasmussen, [email protected]

GP = General Practitioner

Page 10: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Prevalence QuantityCumulative

Effect

Jakob Fraes Rasmussen, [email protected]

GP = General Practitioner

Page 11: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Jakob Fraes Rasmussen, [email protected]

Incl. C

T-sc

reen

ing

scan

Excl. C

T-sc

reen

ing

scan

0200400600800

100012001400160018002000 p<.0001

p=0.52

CT groupControl groupU

SD

Page 12: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

Jakob Fraes Rasmussen, [email protected]

Mean annual healthcare costs per participant in the control group and the diagnostic groups in the DLCST during five screening rounds

Page 13: Methods of analysing healthcare costs in  l ung  c ancer CT-screening

NLST NELSON DLCST0

5

10

15

20

25

Average false-positive rate per screening round

False-positive rate

%

Jakob Fraes Rasmussen, [email protected]

NLST: Aberle DR et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365(5):395-409.

NELSON: van Klaveren RJ et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361(23):2221-2229.

DLCST: Saghir Z et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 2012; 67(4):296-301.